AVDL
Avadel Pharmaceuticals
AVDL
AVDL
82 hedge funds and large institutions have $75.5M invested in Avadel Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.59% less ownership
Funds ownership: 60.74% → 57.15% (-3.6%)
67% less capital invested
Capital invested by funds: $230M → $75.5M (-$155M)
Holders
82
Holding in Top 10
1
Calls
$2.87M
Puts
$2.41M
Top Buyers
| 1 | +$3.47M | |
| 2 | +$1.93M | |
| 3 | +$1.57M | |
| 4 |
Two Sigma Investments
New York
|
+$1.14M |
| 5 |
MWM
Modera Wealth Management
Westwood,
New Jersey
|
+$1.03M |
Top Sellers
| 1 | -$20.4M | |
| 2 | -$11.4M | |
| 3 | -$9.63M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$6.5M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.96M |